IDiyas

For the Inventor, By the Inventor

Tokushima, Japan

Takaji Honna

USPTO Granted Patents = 15

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Tokushima, JP (1980 - 1988)
  • Tokyo, JP (1993 - 1995)

Company Filing History:

goldMedal15 out of 318 
 
Taiho Pharmaceutical Company Limited
 patents

Years Active: 1980-1995

Loading Chart...
15 patents (USPTO):
1. 5447944 - Carbamoyl-2-pyrrolidinone compounds (1995-09-05),
2. 5229402 - Carbamoyl-2-pyrrolidinone compounds (1993-07-20),
3. 4777259 - Rhodanine derivatives and process for preparing the same (1988-10-11),
4. 4714765 - Rhodanine derivatives and process for preparing the same (1987-12-22),
5. 4696929 - Derivative of piperazine having anti-allergic and anti-inflammatory (1987-09-29),
6. 4666911 - Allophanoylpiperazine compound and analgesic composition containing same (1987-05-19),
7. 4518712 - Piperazine derivative and analgesic composition containing the same (1985-05-21),
8. 4371544 - Pharmaceutical composition containing 1,1,3,5-substituted biuret compound (1983-02-01),
9. 4350700 - Pharmaceutical composition containing 1,3,5-substituted biuret compound (1982-09-21),
10. 4293713 - Novel 1,1,3,5-substituted biuret compound and a pharmaceutical (1981-10-06),
11. 4287207 - Pharmaceutical composition containing 1,3,5-substituted biuret compound (1981-09-01),
12. 4278672 - Pharmaceutical composition and methods of use containing (1981-07-14),
13. 4243812 - Processes for the preparation of glyoxal-2-oxims (1981-01-06),
14. 4224450 - Process for the preparation of glyoxal-2-oximes (1980-09-23),
15. 4212874 - Glyoxal-2-oxim derivatives and a process for relieving pain/or (1980-07-15),

Title: Takaji Honna: A Visionary Inventor in Pharmaceutical Innovations

Introduction

Takaji Honna is a prominent inventor based in Tokushima, Japan. With a remarkable portfolio of 15 patents, Honna has significantly contributed to the field of pharmaceuticals, particularly in the development of compounds aimed at improving cerebral functions. His innovative works are celebrated for their potential therapeutic benefits.

Latest Patents

Among Honna's latest innovations is a series of patents related to carbamoyl-2-pyrrolidinone compounds. These compounds are designed to serve as medicaments that aid in enhancing cerebral functions, activating cerebral metabolism, and providing protection against anoxic brain damage. This invention marks a notable advancement in medicinal chemistry and neuroprotective strategies.

Career Highlights

Honna currently works at Taiho Pharmaceutical Company Limited, where he continues to push the boundaries of innovation in the pharmaceutical landscape. His dedication to improving health outcomes through scientific research and development is evident in the patents he has secured over the years.

Collaborations

In his research endeavors, Honna collaborates with esteemed colleagues such as Hidekazu Miyake and Makoto Kajitani. Together, they form a dynamic team committed to advancing pharmaceutical innovations and enhancing clinical applications of their inventions.

Conclusion

Takaji Honna's contributions to the field of pharmaceuticals through his inventive work on carbamoyl-2-pyrrolidinone compounds exemplify the impact that innovative thinking can have on science and healthcare. With his continued research and collaborations, Honna is poised to make further significant advancements in improving cerebral functions, thereby positively influencing the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…